Suppr超能文献

吸入糖皮质激素治疗的哮喘患者中,知识促进依从性量表-12(Adherence Starts with Knowledge-12)的最佳截断值及临床应用价值

Optimal cut-off value and clinical usefulness of the Adherence Starts with Knowledge-12 in patients with asthma taking inhaled corticosteroids.

作者信息

Takemura Masaya, Nishio Masayuki, Fukumitsu Kensuke, Takeda Norihisa, Ichikawa Hiroya, Asano Takamitsu, Tomita Hiroki, Kanemitsu Yoshihiro, Yoshikawa Kosho, Niimi Akio

机构信息

Department of Respiratory Medicine, Allergy and Clinical Immunology, Graduate School of Medical Sciences, Nagoya City University, Nagoya, Japan.

Department of Respiratory Medicine, Social Medical Corporation Kojunkai, Daido Hospital, Daido Clinic, Nagoya, Japan.

出版信息

J Thorac Dis. 2017 Aug;9(8):2350-2359. doi: 10.21037/jtd.2017.06.115.

Abstract

BACKGROUND

Non-adherence to inhalation regimens is common in asthmatic patients. The Adherence Starts with Knowledge-12 (ASK-12) survey was developed to detect and address patient-specific barriers to medication adherence. Our objective is to investigate the clinical usefulness of the ASK-12 for assessing and addressing adherence to inhalation therapy in asthma.

METHODS

The ASK-12 was administered to 138 asthmatic patients. Using pharmacy-refill data, we examined the cut-off value of the ASK-12 to identify patients who were non-adherent to inhalation regimens and identify factors associated with non-adherence. To verify the usefulness of the ASK-12, inhalation regimens were prospectively switched to less-expensive and simpler (once-daily) dosing regimens in eight non-adherent asthmatic patients who reported specific-barriers in "inconvenience of twice-daily inhaler use" and "cost".

RESULTS

Valid responses were received from 114 (82.6%) patients. A significant correlation was found between pharmacy-refill rates and the ASK-12 total score (r=-0.55, P<0.0001). The optimal cut-off value of the ASK-12 total score to discriminate non-adherent patients (defined by pharmacy-refill rate <80%) was 23, with 71.4% specificity and 93.3% sensitivity. Using this value, 52 (45.6%) patients were classified as non-adherent. Univariate followed by multivariate analysis identified younger age as a predictor of non-adherence to inhalation regimens (odds ratio, 2.67; 95% CI, -0.95 to -0.06; P=0.027). Switching inhaled medicines in eight patients resulted in significant improvements in both ASK-12 scores and asthma control.

CONCLUSIONS

The ASK-12 is a brief, practical, and clinically useful measure for assessing and addressing adherence to inhalation regimens in asthma.

摘要

背景

哮喘患者中不坚持吸入治疗方案的情况很常见。开发了“依从性始于知识-12”(ASK-12)调查问卷,以检测并解决患者特定的药物依从性障碍。我们的目的是研究ASK-12在评估和解决哮喘患者吸入治疗依从性方面的临床实用性。

方法

对138例哮喘患者进行ASK-12调查。利用药房配药数据,我们研究了ASK-12的临界值,以识别不坚持吸入治疗方案的患者,并确定与不依从相关的因素。为验证ASK-12的实用性,对8例报告了“每日两次吸入器使用不便”和“费用”等特定障碍的不依从哮喘患者,前瞻性地将吸入治疗方案改为更便宜、更简单(每日一次)的给药方案。

结果

114例(82.6%)患者给出了有效回答。发现药房配药率与ASK-12总分之间存在显著相关性(r=-0.55,P<0.0001)。用于区分不依从患者(根据药房配药率<80%定义)的ASK-12总分的最佳临界值为23,特异性为71.4%,敏感性为93.3%。利用该值,52例(45.6%)患者被分类为不依从。单因素分析后进行多因素分析,确定年龄较小是不坚持吸入治疗方案的一个预测因素(比值比,2.67;95%可信区间,-0.95至-0.06;P=0.027)。8例患者更换吸入药物后,ASK-12评分和哮喘控制情况均有显著改善。

结论

ASK-12是一种简短、实用且在临床上有助于评估和解决哮喘患者吸入治疗依从性的方法。

相似文献

6
Assessing adherence to inhaled medication in asthma: Impact of once-daily versus twice-daily dosing frequency. The ATAUD study.
J Asthma. 2018 Sep;55(9):933-938. doi: 10.1080/02770903.2018.1426769. Epub 2018 Feb 20.
7
Derivation and validation of the ASK-12 adherence barrier survey.
Ann Pharmacother. 2009 Oct;43(10):1621-30. doi: 10.1345/aph.1M174. Epub 2009 Sep 23.
8
Evaluation of asthma medication adherence rates and strategies to improve adherence in the underserved population at a Federally Qualified Health Center.
Res Social Adm Pharm. 2017 Jul-Aug;13(4):759-766. doi: 10.1016/j.sapharm.2016.07.007. Epub 2016 Aug 3.

引用本文的文献

3
Trust, Multidimensional Health Literacy, and Medication Adherence among Patients Undergoing Long-Term Hemodialysis.
Clin J Am Soc Nephrol. 2024 Apr 1;19(4):463-471. doi: 10.2215/CJN.0000000000000392. Epub 2023 Dec 21.
5
Barriers to adherence to iron chelation therapy among adolescent with transfusion dependent thalassemia.
Front Pediatr. 2022 Oct 6;10:951947. doi: 10.3389/fped.2022.951947. eCollection 2022.
6
The Roles of Busyness and Daily Routine in Medication Management Behaviors Among Older Adults.
J Appl Gerontol. 2022 Dec;41(12):2566-2573. doi: 10.1177/07334648221120246. Epub 2022 Aug 11.
7
The impact of adherence and therapy regimens on quality of life in patients with congenital adrenal hyperplasia.
Clin Endocrinol (Oxf). 2022 May;96(5):666-679. doi: 10.1111/cen.14676. Epub 2022 Jan 17.
10
Mobile Health App for Japanese Adult Patients With Asthma: Clinical Observational Study.
J Med Internet Res. 2020 Aug 14;22(8):e19006. doi: 10.2196/19006.

本文引用的文献

1
Evaluation of asthma medication adherence rates and strategies to improve adherence in the underserved population at a Federally Qualified Health Center.
Res Social Adm Pharm. 2017 Jul-Aug;13(4):759-766. doi: 10.1016/j.sapharm.2016.07.007. Epub 2016 Aug 3.
2
A summary of the new GINA strategy: a roadmap to asthma control.
Eur Respir J. 2015 Sep;46(3):622-39. doi: 10.1183/13993003.00853-2015. Epub 2015 Jul 23.
4
Pathophysiological characteristics of asthma in the elderly: a comprehensive study.
Ann Allergy Asthma Immunol. 2014 Nov;113(5):527-33. doi: 10.1016/j.anai.2014.08.002. Epub 2014 Sep 10.
5
Asthma medication use among U.S. adults 18 and older.
Res Social Adm Pharm. 2014 Nov-Dec;10(6):e113-e123. doi: 10.1016/j.sapharm.2014.02.006. Epub 2014 Mar 1.
7
Real-world effects of once vs greater daily inhaled corticosteroid dosing on medication adherence.
Ann Allergy Asthma Immunol. 2013 Sep;111(3):216-20. doi: 10.1016/j.anai.2013.06.008. Epub 2013 Jul 12.
8
Efficacy of using the Japanese version of the asthma control test for determing the level of asthma control in clinical settings.
Allergol Int. 2012 Dec;61(4):609-17. doi: 10.2332/allergolint.12-OA-0453. Epub 2012 Sep 25.
9
Impact of a network system for providing proper inhalation technique by community pharmacists.
J Asthma. 2012 Jun;49(5):535-41. doi: 10.3109/02770903.2012.663847. Epub 2012 Mar 5.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验